Cor Vasa 2026, 68(5):533-537 | DOI: 10.33678/cor.2026.031

Impact of Stent Overlapping on Clinical Outcomes in Patients with Long Coronary Lesions Undergoing Percutaneous Coronary Intervention

Esma Selva Ateş Ceyhun
Department of Cardiology, Erzurum City Hospital, Erzurum, Turkey

Background: Percutaneous coronary intervention is widely used in the treatment of coronary artery disease. Long coronary lesions frequently require implantation of more than one stent, which may lead to overlapping stent segments. Increased metal burden and altered vascular healing in the overlapping region may contribute to adverse clinical outcomes.

Methods: This study evaluated patients who underwent percutaneous coronary intervention for long coronary lesions. Patients were divided into two groups according to the stenting strategy: overlapping stent implantation and single long stent implantation. Clinical outcomes including major adverse cardiovascular events, myocardial infarction, target lesion revascularization, stent thrombosis, and mortality were assessed during follow-up.

Results: Patients treated with overlapping stents demonstrated numerically higher rates of adverse clinical events without reaching statistical significance. In particular, target lesion revascularization and stent thrombosis were observed more frequently in the overlapping stent group.

Conclusion: Overlapping stent implantation in the treatment of long coronary lesions may be associated with a trend toward increased risk of adverse cardiovascular events. Careful selection of stenting strategy may help improve clinical outcomes in these patients.

Keywords: Coronary artery disease, Drug-eluting stents, Long coronary lesions, Percutaneous coronary intervention, Stent overlap

Received: March 9, 2026; Revised: March 22, 2026; Accepted: March 24, 2026; Prepublished online: October 5, 2026; Published: October 20, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ateş Ceyhun ES. Impact of Stent Overlapping on Clinical Outcomes in Patients with Long Coronary Lesions Undergoing Percutaneous Coronary Intervention. Cor Vasa. 2026;68(5):533-537. doi: 10.33678/cor.2026.031.
Download citation

References

  1. Stone GW, Ellis SG, Cox DA, et al. A polymer-based paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231. Go to original source... Go to PubMed...
  2. Kastrati A, Mehilli J, Dirschinger J, et al. Restenosis after coronary placement of various stent types. J Am Coll Cardiol 2001;38:1499-1505. Go to original source... Go to PubMed...
  3. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis. Circulation 2007;115:2435- 2441. Go to original source...
  4. Chhatriwalla AK, Cam A, Unzek S, et al. Drug-eluting stent overlap and clinical outcomes. Circ Cardiovasc Interv 2011;4:146-152.
  5. Räber L, Juni P, Löffel L, et al. Impact of stent overlap on angiographic and long-term clinical outcomes in patients treated with drug-eluting stents. J Am Coll Cardiol 2010;55:1178-1188. Go to original source...
  6. astrati A, Schömig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436. Go to original source...
  7. Lee SH, Jang Y, Oh SJ, et al. Overlapping vs. one long stenting in long coronary lesions. Catheter Cardiovasc Interv 2004;623:298-302. Go to original source...
  8. Kereiakes DJ, Wang H, Popma JJ, et al. Periprocedural and late consequences of overlapping drug-eluting stents: insights from the TAXUS clinical trials. J Am Coll Cardiol 2006;48:21-31. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.